| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
6 companies
Johnson & Johnson is 10% Owner at KVUE and has filed Form 4s across 6 companies. Johnson & Johnson's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $3.9B at current prices.
The biggest single holding is KVUE (~$3.5B) as 10% Owner.
Johnson & Johnson has 12 Form 4 filings on record from March 2015 to November 2025, across 6 companies: 10% Owner at CVRx (CVRX), 2021–2025; 10% Owner at Kenvue (KVUE), 2023; 10% Owner at Inspire Medical Systems (INSP), 2018, and 3 more.
The 35 reported transactions were 15 option exercises, 9 open-market sales, 5 conversions and 3 open-market purchases, plus smaller numbers of other types.
Counted by filing, the open-market trades come to 2 purchases worth about $9.9M and 6 sales worth about $34.7M.
The largest open-market purchase was 583,333 shares of PTGX at an average $12.00 on August 16, 2016, about $7.0M.
The largest open-market sale was 1,514,821 shares of NGNE at an average $22.41 on August 11, 2015, about $33.9M.
None of the 5 sales since April 2023 was marked as made under a Rule 10b5-1 trading plan.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 26, 2025 | CVRX Cvrx, Inc. | 10% Owner | Sell | 6,337 | $10.03 | $63,560.11 | -0.2% | - | - | |
| Nov 24, 2025 | CVRX Cvrx, Inc. | 10% Owner | Sell | 2,700 | $10.05 | $27,132.00 | - | - | - | |
| Nov 12, 2025 | CVRX Cvrx, Inc. | 10% Owner | Sell | 1,000 | $10.00 | $10,000.00 | - | - | - | |
| Nov 7, 2025 | CVRX Cvrx, Inc. | 10% Owner | Sell | 52,532 | $10.21 | $536,309.72 | -1.3% | - | - | |
| Feb 16, 2024 | CVRX Cvrx, Inc. | 10% Owner | Sale+OE | 3,725 | $25.81 | $96,142.25 | - | - | - | |
| Aug 16, 2016 | PTGX Protagonist Therapeutics, Inc | 10% Owner | Buy | 583,333 | $12.00 | $6,999,996.00 | +31.3% | - | - | |
| Aug 11, 2015 | NGNE Neurogene Inc. | 10% Owner | Sell | 1,514,821 | $22.41 | $33,944,876.14 | -93.8% | - | - | |
| Mar 13, 2015 | NERV Minerva Neurosciences, Inc. | 10% Owner | Buy | 607,903 | $4.81 | $2,924,013.43 | +15.6% | - | - |